<p>PVTT-1 cells expressing GFP-tagged p53 shRNA (p53KD) and/or ICAT were treated with insulin (10 μg/ml) and TGF-β1 (5 ng/ml) as indicated and used in a wound healing assay (<b>A</b>) and a transwell assay (<b>B</b>). For wound healing assay, representative images of GFP-positive cells at 48 h after wound scratching are shown (X200) and the results from three independent experiments are shown in the right as mean ± SD. For transwell assay, the migrated cells on the bottom surface of each well were fixed and stained and the representative images are shown (X100). The area of migrated cells per field was quantified and shown in the right as mean ± SD (n = 8). * and ** indicate p<0.05 and p<0.01 respectively between the corresponding groups in...
<p>(A) A Boyden chamber assay was used to measure the migration of gastric cancer cells. 10% FBS was...
<p>(A) The wound healing assay was employed to determine the migration of SMMC-7721 cells, cells wer...
With few curative treatments and a global yearly death rate of over 800,000, hepatocellular carcinom...
<p>Wild type or p53-silenced (p53KD) PVTT-1 cells were treated with or without insulin (10 μg/ml) an...
<p>PVTT-1 cells selected for the expression of ICAT and p53 shRNA (p53KD) were injected into the lef...
<div><p>Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the biggest obstacle ...
Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the biggest obstacle in curin...
Loss of function of the tumor suppressor p53 is known to increase the rate of migration of cells tra...
Background: Abnormal p53 expression has been observed in gastric carcinoma cells. The question of wh...
Loss of function of the tumor suppressor p53 is known to increase the rate of migration of cells tra...
<p>(<b>a</b>) Wound healing assays were performed on SKOV3 and OVCA 420 stable cell lines. Cell mono...
The p53 tumor suppressor plays a central role in the negative control of growth and survival of abno...
<p>(A) Wound healing assay was performed to evaluate the migration of PANC-1 and HPAC cells after si...
<p><b>A.</b> Boyden chamber assay was used to determine the invasiveness of Huh7 and Hep3B cells upo...
Chemoresistance is a major problem in the treatment of hepatocellular carcinoma. Certain p53 mutants...
<p>(A) A Boyden chamber assay was used to measure the migration of gastric cancer cells. 10% FBS was...
<p>(A) The wound healing assay was employed to determine the migration of SMMC-7721 cells, cells wer...
With few curative treatments and a global yearly death rate of over 800,000, hepatocellular carcinom...
<p>Wild type or p53-silenced (p53KD) PVTT-1 cells were treated with or without insulin (10 μg/ml) an...
<p>PVTT-1 cells selected for the expression of ICAT and p53 shRNA (p53KD) were injected into the lef...
<div><p>Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the biggest obstacle ...
Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the biggest obstacle in curin...
Loss of function of the tumor suppressor p53 is known to increase the rate of migration of cells tra...
Background: Abnormal p53 expression has been observed in gastric carcinoma cells. The question of wh...
Loss of function of the tumor suppressor p53 is known to increase the rate of migration of cells tra...
<p>(<b>a</b>) Wound healing assays were performed on SKOV3 and OVCA 420 stable cell lines. Cell mono...
The p53 tumor suppressor plays a central role in the negative control of growth and survival of abno...
<p>(A) Wound healing assay was performed to evaluate the migration of PANC-1 and HPAC cells after si...
<p><b>A.</b> Boyden chamber assay was used to determine the invasiveness of Huh7 and Hep3B cells upo...
Chemoresistance is a major problem in the treatment of hepatocellular carcinoma. Certain p53 mutants...
<p>(A) A Boyden chamber assay was used to measure the migration of gastric cancer cells. 10% FBS was...
<p>(A) The wound healing assay was employed to determine the migration of SMMC-7721 cells, cells wer...
With few curative treatments and a global yearly death rate of over 800,000, hepatocellular carcinom...